|
CMPX Compass Therapeutics Inc. 1738021 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-18,317,000.00 |
| Balance Sheet |
|
Current Assets
|
$195,687,000.00 |
|
Assets
|
$205,170,000.00 |
|
Current Liabilities
|
$10,279,000.00 |
|
Liabilities
|
$18,697,000.00 |
|
Equity
|
$186,473,000.00 |
|
Shares Out
|
180088000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-17,269,000.00 |
|
Investing Cash Flow
|
$38,429,000.00 |
| Market Analysis |
Market Cap
|
$349,370,720.00 |
|
Price
|
$1.87 |
|
BVPS
|
1.04 |
|
PB
|
1.87 |
|
EPS
|
-0.10 |
|
FCF
|
$-17,351,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:28 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.09 |
|
|
2026-05-05 |
-0.10 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.14 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.08 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CMPX documents filed with the SEC.
CMPX Filings
Clear
